Fundraising Fox

Starget Pharma

Shreveport, US · Founded 2025 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

SK
Sigal Kalmanson CusnirExecutive

Board

RK
Ronen KalmansonBoard director

Investors · 1

Cancer Focusreported · 2 sourcesHouston

Reported raises · per SEC filings

Form D private placements

$16.4M disclosed across 1 of 2 rounds · 2024–2026

▶$16.4MraisedFeb 2026 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ronen KalmansonDirector
  • Sigal Kalmanson CusnirExecutive Officer
Offering amount
$22.2M
Amount sold
$16.4M
Minimum investment
$50K
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Israeli oncology treatment co Starget Pharma raises $18m - Globesen.globes.co.il · Feb 2026Starget Pharma Raises $18M Series A to Accelerate AI-Powered Radioligand Cancer Therapies and US Expansion | BEAMSTARTbeamstart.com · Feb 2026Starget Pharma raises $18M in series A to advance radioligand therapies By Investing.comuk.investing.com · Feb 2026Starget Pharma Closes $18M Series A Financing and Announces Strategic Collaboration with Center for Molecular Imaging and Therapy in Louisianaprnewswire.com · Feb 2026Israeli biotech Starget secures $18 million Series A to accelerate precision cancer treatments | CTechcalcalistech.com · Feb 2026Cancer Focus Fund Invests $5.1 Million in Starget Pharma to Support Phase 1b Clinical Trial of Novel Peptide Radioligand for Precision Cancer Therapy — CFFcancerfocusfund.com · Oct 2024

Frequently asked questions

Who are Starget Pharma's investors?
Starget Pharma's investors include Cancer Focus.
How much funding has Starget Pharma raised?
Starget Pharma has disclosed $16.4M raised across 1 of its 2 known rounds.
Where is Starget Pharma headquartered?
Starget Pharma is headquartered in Shreveport, US.